The Hooshmand Lab participated in the ACS Fall 2025 Meeting in the Colloids Division, presenting our poster on a nanoparticle-based electrochemical sensor for early cancer detection. Our work demonstrated how cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) can distinguish normal pancreatic cells from cancer cells, creating unique electrochemical fingerprints. This simple and low-cost platform shows promise for real-time cancer diagnostics, opening the door to earlier detection and improved patient outcomes.
